Trial intelligence / Profile preview

Babaodan capsule plus levofloxacin for acute pyelonephritis

ChiCTR2100045158Phase 4Recruiting

Sponsor
Shantou Central Hospital
Start
May 2021
Countries
1
01

Overview

Phase 4 trial of Babaodan in acute pyelonephritis (2 arms), sponsored by Shantou Central Hospital. Primary endpoints: Urine culture results, Main symptoms and signs and comprehensive curative effect and 1 more. Started May 2021; status: recruiting.

02

Drugs

Babaodan
03

Conditions

acute pyelonephritis

Beyond the preview

Go deeper on ChiCTR2100045158.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100045158.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call